Average Co-Inventor Count = 3.89
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Theravance, Inc. (33 from 386 patents)
2. Theravance Biopharma R&d Ip, LLC (18 from 262 patents)
3. Theravance Respiratory Company, LLC (10 from 12 patents)
61 patents:
1. 11723900 - 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
2. 10946007 - 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
3. 10836744 - Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
4. 10722504 - 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
5. 10590107 - Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
6. 10441579 - 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
7. 10358433 - Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
8. 10206913 - 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
9. 10138220 - Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity
10. 10034870 - 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
11. 9975875 - Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
12. 9771350 - [object Object]
13. 9682957 - [object Object]
14. 9675599 - 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
15. 9572802 - [object Object]